CompletedNCT01447082
Quetiapine XR and Other Medicines: Safety in Routine Care
About this title
Read the official source — NCT01447082Observational studyAges 18–85SwitzerlandDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 85 years.
- Listed locations
- BaselSee all locations and recruitment
Study information
Study start dateOctober 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 37,372
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Switzerland
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT01447082
- Official title
Show the full official title
Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Basel
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 85 years.
